BRPI0411798A - sistemas e métodos para separar e concentrar células regenerativas do tecido - Google Patents

sistemas e métodos para separar e concentrar células regenerativas do tecido

Info

Publication number
BRPI0411798A
BRPI0411798A BRPI0411798-0A BRPI0411798A BRPI0411798A BR PI0411798 A BRPI0411798 A BR PI0411798A BR PI0411798 A BRPI0411798 A BR PI0411798A BR PI0411798 A BRPI0411798 A BR PI0411798A
Authority
BR
Brazil
Prior art keywords
systems
methods
separating
regenerative cells
tissue
Prior art date
Application number
BRPI0411798-0A
Other languages
English (en)
Inventor
Marc H Hedrick
John K Fraser
Michael J Schulzki
Bobby Byrnes
Grace Carison
Original Assignee
Macropore Biosurgery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macropore Biosurgery Inc filed Critical Macropore Biosurgery Inc
Publication of BRPI0411798A publication Critical patent/BRPI0411798A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/08Apparatus for tissue disaggregation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B04CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
    • B04BCENTRIFUGES
    • B04B5/00Other centrifuges
    • B04B5/04Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
    • B04B5/0442Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B04CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
    • B04BCENTRIFUGES
    • B04B5/00Other centrifuges
    • B04B5/04Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
    • B04B5/0407Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers for liquids contained in receptacles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/14Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M45/00Means for pre-treatment of biological substances
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B04CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
    • B04BCENTRIFUGES
    • B04B5/00Other centrifuges
    • B04B5/04Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
    • B04B5/0442Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation
    • B04B2005/0471Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation with additional elutriation separation of different particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

"SISTEMAS E MéTODOS PARA SEPARAR E CONCENTRAR CéLULAS REGENERATIVAS DO TECIDO". Os sistemas e métodos descritos são utilizados para separar células de uma ampla variedade de tecidos. Em particular, os sistemas e métodos automatizados separam células regenerativas, por exemplo, células tronco e/ou progenitoras, do tecido adiposo. Os sistemas e métodos descritos na presente invenção fornece métodos rápidos e confiáveis de separar e concentrar células regenerativas adequadas para a re-infusão em um indivíduo.
BRPI0411798-0A 2003-06-25 2004-06-25 sistemas e métodos para separar e concentrar células regenerativas do tecido BRPI0411798A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48282003P 2003-06-25 2003-06-25
US49646703P 2003-08-20 2003-08-20
PCT/US2004/020594 WO2005012480A2 (en) 2003-06-25 2004-06-25 Systems and methods for separating and concentrating regenerative cells from tissue

Publications (1)

Publication Number Publication Date
BRPI0411798A true BRPI0411798A (pt) 2006-08-08

Family

ID=34118676

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411798-0A BRPI0411798A (pt) 2003-06-25 2004-06-25 sistemas e métodos para separar e concentrar células regenerativas do tecido

Country Status (11)

Country Link
EP (2) EP1648999A4 (pt)
JP (2) JP2007524396A (pt)
KR (1) KR101127305B1 (pt)
CN (1) CN1842589B (pt)
AU (1) AU2004260937B2 (pt)
BR (1) BRPI0411798A (pt)
CA (1) CA2530630A1 (pt)
HK (1) HK1096424A1 (pt)
IL (1) IL172800A0 (pt)
MX (1) MXPA06000062A (pt)
WO (1) WO2005012480A2 (pt)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
KR101083454B1 (ko) 2001-12-07 2011-11-16 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한 시스템 및 방법
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
KR20070002058A (ko) * 2004-03-19 2007-01-04 사이토리 테라퓨틱스, 인크. 재생 세포를 함유하는 세포 운반체 및 세포 운반체 수용장치
ES2351341T3 (es) * 2004-07-01 2011-02-03 Cytori Therapeutics, Inc. Procedimientos de uso de células regenerativas en el tratamiento de trastornos y enfermedades renales.
DE602004031782D1 (de) * 2004-07-01 2011-04-21 Cytori Therapeutics Inc Verfahren zur verwendung regenerativer zellen zur förderung der wundheilung
EP1765980A4 (en) * 2004-07-02 2007-12-12 Cytori Therapeutics Inc SYSTEMS AND METHOD FOR THE INSULATION AND USE OF CLINICALLY SAFE, FAT-GUN-GENERATING REGENERATIVE CELLS
US8062286B2 (en) 2005-03-23 2011-11-22 Shippert Ronald D Tissue transplantation method and apparatus
US7789872B2 (en) 2005-03-23 2010-09-07 Shippert Ronald D Tissue transplantation method and apparatus
US7794449B2 (en) 2005-03-23 2010-09-14 Shippert Ronald D Tissue transplantation method and apparatus
US8622997B2 (en) 2005-03-23 2014-01-07 Ronald D. Shippert Tissue transfer method and apparatus
US9581942B1 (en) 2005-03-23 2017-02-28 Shippert Enterprises, Llc Tissue transfer method and apparatus
US7780649B2 (en) 2005-03-23 2010-08-24 Shippert Ronald D Tissue transplantation method and apparatus
EP2465923B1 (en) * 2005-05-25 2018-04-11 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US9057052B2 (en) 2005-10-21 2015-06-16 Kaneka Corporation Stem cell separating material and method of separation
JP4928831B2 (ja) * 2006-05-25 2012-05-09 株式会社カネカ 自動培養装置
WO2008099696A1 (ja) * 2007-02-16 2008-08-21 Olympus Corporation 脂肪消化終了判定装置および脂肪組織消化装置
JP2008212021A (ja) * 2007-03-01 2008-09-18 Olympus Corp 生体組織の分解状況判定方法および生体組織分解装置
JP5493855B2 (ja) * 2007-04-27 2014-05-14 東洋製罐グループホールディングス株式会社 細胞培養装置、細胞培養システム及び細胞培養方法
JP5190861B2 (ja) 2007-05-11 2013-04-24 オリンパス株式会社 生体組織分解方法
JP2008278822A (ja) 2007-05-11 2008-11-20 Olympus Corp 生体組織分解方法
JP2009095309A (ja) * 2007-10-18 2009-05-07 Olympus Corp 生体組織分解装置および生体組織分解方法
JP2009136172A (ja) * 2007-12-04 2009-06-25 Olympus Corp 細胞処理装置
JP2009136168A (ja) * 2007-12-04 2009-06-25 Olympus Corp 細胞分離装置
DK2520643T3 (da) * 2007-12-07 2020-01-20 Miltenyi Biotec Bv & Co Kg Prøvebehandlingssystemer og -fremgangsmåder
GB0800311D0 (en) * 2008-01-09 2008-02-20 Cytosystems Ltd Apparatus and method for filtering biological material
JP2009189281A (ja) * 2008-02-13 2009-08-27 Olympus Corp 細胞処理装置
KR101005938B1 (ko) * 2008-03-28 2011-01-06 이희영 지지체의 제조방법 및 장치
FR2931838B1 (fr) * 2008-06-02 2010-06-11 Millipore Corp Installation pour traiter un liquide biologique.
KR101044371B1 (ko) * 2008-06-05 2011-06-29 이희영 줄기세포 분리를 위한 혼합장치
AU2009281809B2 (en) 2008-08-14 2015-09-17 Mesoblast International Sarl Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
JP2010075066A (ja) 2008-09-24 2010-04-08 Olympus Corp 遠心分離容器
WO2010047793A2 (en) 2008-10-21 2010-04-29 The General Hospital Corporation Cell transplantation
JP2010127620A (ja) * 2008-11-25 2010-06-10 Olympus Corp 生体組織処理装置
JP2010148450A (ja) 2008-12-25 2010-07-08 Olympus Corp 細胞洗浄方法
JP2010207318A (ja) * 2009-03-09 2010-09-24 Olympus Corp 生体組織採取装置
JP5917392B2 (ja) 2009-05-01 2016-05-11 ビミニ テクノロジーズ リミテッド ライアビリティ カンパニー 組織及び細胞富化グラフトを最適化するシステム、方法及び組成物
KR101679671B1 (ko) * 2009-10-27 2016-11-28 도병록 재생성 세포 추출 시스템
KR101316573B1 (ko) * 2009-10-27 2013-10-15 도병록 재생성 세포 추출유닛 및 재생성 세포 추출시스템
JP5710885B2 (ja) * 2010-02-25 2015-04-30 オリンパス株式会社 脂肪由来細胞の賦活化方法および移植材の製造方法
EP2589652A4 (en) * 2010-07-01 2017-04-05 Kaneka Corporation Disposable set for cell culture, cell culture device and cell preparation method
US10184110B2 (en) 2010-08-06 2019-01-22 The General Hospital Corporation System and apparatus for cell treatment
JP5837742B2 (ja) * 2010-08-27 2015-12-24 学校法人東京女子医科大学 細胞単離装置
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
GB201103917D0 (en) * 2011-03-08 2011-04-20 Univ Leiden Apparatus for and methods of processing liquids or liquid based substances
US8887770B1 (en) 2011-03-17 2014-11-18 Ronald D. Shippert Vessel fill control method and apparatus
US10934519B2 (en) * 2011-07-29 2021-03-02 Global Life Sciences Solutions Usa Llc Systems, methods and control laws for cell harvesting
WO2013030761A1 (en) * 2011-08-29 2013-03-07 Stempeutics Research Private Limited A system for isolating stromal vascular fraction (svf) cells from the adipose tissue and a method thereof
US9603356B2 (en) 2011-10-24 2017-03-28 Kaneka Corporation Method for producing cell concentrate
WO2013086183A1 (en) * 2011-12-07 2013-06-13 Huang Lotien R Method and device for sample processing
CN103203043A (zh) * 2012-01-12 2013-07-17 刘云松 用于分离原代脂肪干细胞的储脂桶及其使用方法
DE102013209718B4 (de) * 2012-06-22 2015-09-10 Human Med Ag Vorrichtung zum Separieren von adulten Stammzellen
BR112015001905A2 (pt) * 2012-08-27 2017-07-04 Stempeutics Res Private Limited sistema de misturador e separador de múltiplos planos (mpms)
US9624207B2 (en) 2012-08-27 2017-04-18 Hetero Research Foundation Polymorphs of azilsartan medoxomil
EP2891710B1 (en) 2012-08-30 2018-10-17 Kaneka Corporation Method for producing cell concentrate
US9468709B2 (en) 2012-11-12 2016-10-18 Shippert Enterprises, Llc Syringe fill method and apparatus
US20140162355A1 (en) * 2012-12-07 2014-06-12 Antria, Inc. Formulations Containing and Kit for Using Adipose-Derived Stem Cells and Use Thereof
CA2903943A1 (en) * 2013-03-04 2014-09-12 Swiss Stem Cell Foundation A system for extraction of cells from a sample of tissue
US9580678B2 (en) 2013-06-21 2017-02-28 The Regents Of The University Of California Microfluidic tumor tissue dissociation device
KR101354959B1 (ko) * 2013-07-09 2014-01-22 김태영 줄기세포 분리기
US10113144B2 (en) 2013-07-23 2018-10-30 Kaneka Corporation Method for producing cell concentrate, and cell suspension treatment system
US20160206661A1 (en) * 2013-09-19 2016-07-21 John Fraser Methods of using adipose tissue-derived cells in the modulation of pain and/or fibrosis
WO2015056997A1 (ko) * 2013-10-18 2015-04-23 메디칸(주) 소립자 물질 정제장치 및 정제방법
US9726687B2 (en) 2013-11-13 2017-08-08 Stempeutics Research Private Limited System and method for processing of biological tissue samples
CN105992816B (zh) 2013-11-16 2018-04-17 泰尔茂比司特公司 生物反应器中的细胞扩增
US20150182558A1 (en) * 2014-01-02 2015-07-02 PSC Cosmetics Ltd. Method and apparatus for harvesting, creating and implanting a fibrin clot biomaterial
KR101594539B1 (ko) * 2014-02-17 2016-02-16 한국기초과학지원연구원 세포 응집용 농축 시험관
EP3613841B1 (en) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passive replacement of media
WO2015149098A1 (de) 2014-03-31 2015-10-08 Liporegena Gmbh Vorrichtung zur entnahme und portionierung von fettgewebe
US10772997B2 (en) 2014-05-15 2020-09-15 Ronald D. Shippert Tissue parcelization method and apparatus
JP6830059B2 (ja) 2014-09-26 2021-02-17 テルモ ビーシーティー、インコーポレーテッド スケジュール化された細胞フィーディング
US9931436B2 (en) * 2015-02-02 2018-04-03 Kerastem Technologies LLC Methods and devices to stimulate the follicular niche using adipose derived regenerative cells and adipose tissue
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN107735120B (zh) * 2015-07-13 2021-06-15 美国血液技术公司 用于从回收的血液中清除脂肪的系统和方法
KR101698018B1 (ko) * 2015-09-02 2017-01-19 주식회사 베스테크 의료용 재생성세포 추출장치
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells
JP7037510B2 (ja) 2016-03-17 2022-03-16 シノヴァ ライフ サイエンシーズ,インコーポレイテッド 衝撃波または機械的衝撃を使用する、細胞の分離、解離、および/または脱凝集
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
CA3051051A1 (en) 2016-06-08 2017-12-14 The Regents Of The University Of California Method and device for processing tissues and cells
WO2018031654A1 (en) * 2016-08-09 2018-02-15 Arteriocyte, Inc. Device and methods for harvesting fat derived microvessel segments
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
JP6256786B1 (ja) * 2017-04-12 2018-01-10 学校法人福岡大学 不妊症の処置に用いられる医薬組成物およびその製造方法
JP7282679B2 (ja) * 2017-09-15 2023-05-29 株式会社カネカ 細胞含有試料からの細胞の遊離方法
WO2019059279A1 (ja) * 2017-09-20 2019-03-28 株式会社カネカ 細胞懸濁液を調製するためのデバイス、システム及び方法
EP3461511B1 (en) * 2017-09-29 2022-04-20 Fenwal, Inc. Systems and methods for processing large volumes of biological fluid
GB201720405D0 (en) 2017-12-07 2018-01-24 Biosafe Sa A bioprocessing system
KR102196527B1 (ko) 2017-12-21 2020-12-31 한양대학교 산학협력단 적혈구계 세포 배양 중 적혈구를 수거하기 위한 시스템 및 방법
CN108106922A (zh) * 2018-01-31 2018-06-01 迈克医疗电子有限公司 一种浓缩混匀机构
US20210155892A1 (en) * 2018-07-27 2021-05-27 Univercells Technologies S.A. System and method for the production of biomolecules
EP3893949A4 (en) * 2018-12-13 2022-08-17 Koligo Therapeutics, Inc. CELL SEPARATION DEVICE AND METHODS OF USE
CA3133462A1 (en) * 2019-03-26 2020-10-01 Megakaryon Corporation Cell suspension treatment apparatus
CN111678750A (zh) * 2020-04-24 2020-09-18 苏州格目软件技术有限公司 一种基于离心分离的生物检测平台
WO2022094613A1 (en) * 2020-10-29 2022-05-05 Renovacare Sciences Corp. Cell isolation device and methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146172A (en) * 1977-10-18 1979-03-27 Baxter Travenol Laboratories, Inc. Centrifugal liquid processing system
US4526515A (en) * 1979-12-06 1985-07-02 Baxter Travenol Laboratories, Inc. Fluid pumping assembly including a prepackaged fluid circuit module
JPS5990649A (ja) * 1982-11-12 1984-05-25 Hitachi Koki Co Ltd 無菌式連続遠心分離システム
JPH01141583A (ja) * 1987-11-27 1989-06-02 Shimadzu Corp 細胞処理チャンバ
JP2564611B2 (ja) * 1988-06-13 1996-12-18 株式会社日立製作所 生物細胞用遠心分離装置及び細胞の分離方法
JPH0666B2 (ja) * 1989-05-02 1994-01-05 倉敷紡績株式会社 Dnaの単離精製法
US5641622A (en) * 1990-09-13 1997-06-24 Baxter International Inc. Continuous centrifugation process for the separation of biological components from heterogeneous cell populations
JPH0675497B2 (ja) * 1990-11-15 1994-09-28 倉敷紡績株式会社 プラスミド分離装置
JP2637297B2 (ja) * 1991-02-22 1997-08-06 帝人株式会社 遠心分離装置
NZ242533A (en) * 1991-05-03 1995-05-26 Becton Dickinson Co Device for collecting and processing fat tissue; vessel with rinsing and digesting chamber, drain chamber and isolation chamber
CA2140455A1 (en) * 1993-05-28 1994-12-08 William C. Lake Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations
US6238908B1 (en) 1995-06-07 2001-05-29 Aastrom Biosciences, Inc. Apparatus and method for maintaining and growth biological cells
US6280473B1 (en) 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US5919234A (en) 1996-08-19 1999-07-06 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US6269716B1 (en) 1998-11-18 2001-08-07 Macropore, Inc. High-torque resorbable screws
EP1069874B1 (en) 1998-04-07 2005-01-12 Macropore, Inc. Membrane with tissue-guiding surface corrugations
US6001642A (en) 1998-06-29 1999-12-14 Wyle Laboratories, Inc. Life Sciences Bioreactor and cell culturing processes using the bioreactor
JP4195250B2 (ja) * 1999-03-12 2008-12-10 株式会社神鋼環境ソリューション ビール等の発酵食品類の製造方法
JP4014350B2 (ja) * 1999-03-12 2007-11-28 株式会社神鋼環境ソリューション 酵母液貯留用攪拌槽と、その攪拌槽を用いたビール等の発酵食品類の製造方法、並びにその攪拌槽に具備された攪拌翼
WO2001036663A2 (en) 1999-11-15 2001-05-25 Chemclean Corporation Bio-burden visualization system
JP3524835B2 (ja) * 2000-02-25 2004-05-10 財団法人地球環境産業技術研究機構 光合成培養装置及び培養方法
ATE296069T1 (de) 2000-03-10 2005-06-15 Macropore Biosurgery Inc Resorbierbare mikromembrane zur verminderung von narbengewebe
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
AU2002211449A1 (en) 2000-10-04 2002-04-15 James Peter Amis Non-scatterable, radio-opaque marker for medical imaging applications
US20030054331A1 (en) * 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
KR101083454B1 (ko) * 2001-12-07 2011-11-16 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한 시스템 및 방법

Also Published As

Publication number Publication date
AU2004260937A1 (en) 2005-02-10
CN1842589A (zh) 2006-10-04
MXPA06000062A (es) 2006-04-07
JP5604397B2 (ja) 2014-10-08
JP2007524396A (ja) 2007-08-30
KR20060030861A (ko) 2006-04-11
EP1648999A2 (en) 2006-04-26
JP2012075439A (ja) 2012-04-19
HK1096424A1 (en) 2007-06-01
AU2004260937B2 (en) 2010-05-13
KR101127305B1 (ko) 2012-04-23
EP2380970A1 (en) 2011-10-26
CN1842589B (zh) 2012-04-25
EP2380970B1 (en) 2017-12-20
WO2005012480A2 (en) 2005-02-10
WO2005012480A3 (en) 2005-06-02
EP1648999A4 (en) 2006-09-06
IL172800A0 (en) 2006-06-11
CA2530630A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
BRPI0411798A (pt) sistemas e métodos para separar e concentrar células regenerativas do tecido
BRPI0506474A (pt) sistema de tecido com células tronco não diferenciadas derivadas no limbus da córnea
EA200601231A1 (ru) Дефинитивная энтодерма
BRPI0416898A (pt) dispositivos de filtragem de fluxo tangencial e métodos para o enriquecimento de células-tronco
BRPI0417194A (pt) células-tronco
CO5601037A2 (es) Anticuerpos anti-a beta y sus usos
TW200724677A (en) Method for Mesenchymal stem cell identification by use of molecular marker and use thereof
WO2002064748A8 (en) Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
BR0312764A (pt) Cardiomiócitos funcionais originados de células-tronco embrionárias humanas
AR049259A1 (es) Suspensiones de espermatozoides para separar en poblaciones enriquecidas con cromosomas x o y
MX2007007259A (es) Inhibidores de homodimerizacion de myd88.
IL210618A (en) Cell cultures containing isolated and multiplied human cells other than embryonic and germ cells, pharmaceutical preparations containing them, methods of preparation, and methods for identifying modulators and differentiation factors.
Suszynska et al. The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
WO2007039150A3 (en) Cell populations having immunoregulatory activity, method for isolation and uses
BRPI0507822A (pt) método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição autoimune ou infecciosa, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição do sangue, método e composição farmacêutica para modular a formação de células do sangue, método e composição farmacêutica para intensificar a mobilização periférico da célula tronco, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição metabólica, método e composição farmacêutica para a prevenção ou o tratamento das condições associadas com doses mieloablativas de quimioradioterapia suportadas pelo transplante autólogo de medula óssea ou de células tronco do sangue periférico (asct) ou pelo transplante alogenéico de medula óssea (bmt), método e composição farmacêutica para aumentar o efeito de um fator estimulante de células do sangue, método e composição farmacêutica para intensificar a colonização de células tronco do sangue doadas em um receptor mieloablatado, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição bacteriana, composição farmacêutica para o tratamento ou a prevenção de uma indicação selecionada do grupo que consiste em doença ou condição autoimune, doença viral, infecção viral, doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, hiperlipidemia, hipercolesterolemia, glucosuria, hiperglicemia, diabetes, aids, hiv-1, distúrbios de células t auxiliares, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, distúrbios do sistema imunológico resultantes da terapia de quimioterapia ou de radiação, distúrbios do sistema imunológico humano resultantes do tratamento das doenças de deficiência imunológica e infecções bacterianas, composição farmacêutica para o tratamento ou a prevenção de um indicação selecionada do grupo que consiste em doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, sìndrome mielodisplástiacas, malignidades não mielóides, anemia plástica e insuficiência da medula óssea, peptìdeo purificado, peptìdeo quimérico purificado, peptìdeo quimérico, composição farmacêutica, composição farmacêutica para a prevenção ou o tratamento de uma condição associada com um agente infeccioso de sars, método de processamento a baixa temperatura de hidrolisato proteolìtico de caseìna e hidrolisato de proteìna de caseìna
BR0308919A (pt) Células-tronco programáveis, desdiferenciadas de origem monocìtica, e sua produção e uso
PE20110358A1 (es) Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias
WO2006060709A3 (en) Biological pathways in progenitor cells
NO20092741L (no) DR6-antagonister og anvendelse derav ved behandling av neurologiske forstyrrelser
TR200200662T2 (tr) Alzheimer hastalığı sekretazı
BRPI0416574A (pt) tratamento autólogo de disco degenerado com células
CO6290699A2 (es) Termoestabilizacion de proteinas
BRPI0410562A (pt) molécula recombinante e veìculo para expressão, liberação e purificação de polipeptìdeos alvo
ES2421558T3 (es) Anticuerpos específicos de cáncer y proteínas de superficie celular

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: REF. A RPI NO 2228 DE 17/09/2013.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements